These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8613944

  • 1. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
    Maiorino RM, Xu ZF, Aposhian HV.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944
    [Abstract] [Full Text] [Related]

  • 2. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
    Maiorino RM, Weber GL, Aposhian HV.
    Drug Metab Dispos; 1988 Apr; 16(3):455-63. PubMed ID: 2900740
    [Abstract] [Full Text] [Related]

  • 3. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
    Maiorino RM, Dart RC, Carter DE, Aposhian HV.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628
    [Abstract] [Full Text] [Related]

  • 4. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
    Maiorino RM, Akins JM, Blaha K, Carter DE, Aposhian HV.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
    [Abstract] [Full Text] [Related]

  • 5. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.
    Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC, Aposhian HV.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):662-8. PubMed ID: 8113976
    [Abstract] [Full Text] [Related]

  • 6. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
    Stewart JR, Diamond GL.
    Drug Metab Dispos; 1988 Feb; 16(2):189-95. PubMed ID: 2898331
    [Abstract] [Full Text] [Related]

  • 7. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
    Diamond GL, Klotzbach JM, Stewart JR.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
    [Abstract] [Full Text] [Related]

  • 8. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
    Maiorino RM, Bruce DC, Aposhian HV.
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
    [Abstract] [Full Text] [Related]

  • 9. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
    Maiorino RM, Aposhian MM, Xu ZF, Li Y, Polt RL, Aposhian HV.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
    [Abstract] [Full Text] [Related]

  • 10. Protein-thiol substitution or protein dethiolation by thiol/disulfide exchange reactions: the albumin model.
    Summa D, Spiga O, Bernini A, Venditti V, Priora R, Frosali S, Margaritis A, Di Giuseppe D, Niccolai N, Di Simplicio P.
    Proteins; 2007 Nov 01; 69(2):369-78. PubMed ID: 17607746
    [Abstract] [Full Text] [Related]

  • 11. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM.
    Toxicology; 1995 Mar 31; 97(1-3):23-38. PubMed ID: 7716789
    [Abstract] [Full Text] [Related]

  • 12. The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols.
    Di Giuseppe D, Frosali S, Priora R, Di Simplicio FC, Buonocore G, Cellesi C, Capecchi PL, Pasini FL, Lazzerini PE, Jakubowski H, Di Simplicio P.
    J Lab Clin Med; 2004 Nov 31; 144(5):235-45. PubMed ID: 15570241
    [Abstract] [Full Text] [Related]

  • 13. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
    Hsu CA, Aposhian HV, Heydolph S, Parr W.
    J Pharmacol Exp Ther; 1983 Feb 31; 224(2):314-8. PubMed ID: 6687396
    [Abstract] [Full Text] [Related]

  • 14. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
    Aposhian HV, Zheng B, Aposhian MM, Le XC, Cebrian ME, Cullen W, Zakharyan RA, Ma M, Dart RC, Cheng Z, Andrewes P, Yip L, O'Malley GF, Maiorino RM, Van Voorhies W, Healy SM, Titcomb A.
    Toxicol Appl Pharmacol; 2000 May 15; 165(1):74-83. PubMed ID: 10814555
    [Abstract] [Full Text] [Related]

  • 15. In vitro assessment of chelating agents with regard to their abstraction efficiency of Cd(2+) bound to plasma proteins.
    Zeini Jahromi E, Gailer J.
    Metallomics; 2012 Aug 15; 4(9):995-1003. PubMed ID: 22820874
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.